Technology Times Somalia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times Somalia.

Press releases published on June 7, 2026

12 hours ago

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Indeterminate GlobeNewswire

12 hours ago

Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Indeterminate GlobeNewswire

12 hours ago

Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management

Indeterminate GlobeNewswire

12 hours ago

SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation

Indeterminate GlobeNewswire

12 hours ago

NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand

Indeterminate GlobeNewswire

12 hours ago

NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories

Indeterminate GlobeNewswire

14 hours ago

Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes

Indeterminate GlobeNewswire

16 hours ago

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

Indeterminate GlobeNewswire

16 hours ago

Photo Scanning Services 2026 - iMemories Launched Photo Scanning Services for Families Across the USA

Indeterminate GlobeNewswire

17 hours ago

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Indeterminate GlobeNewswire

17 hours ago

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis

Indeterminate GlobeNewswire

18 hours ago

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

Indeterminate GlobeNewswire

Jun. 7, 2026

Astrall Dynamics Unveils Integrated Quadruped Firefighting Robot Hypertron-T01 at INTERSCHUTZ 2026

Indeterminate GlobeNewswire

Jun. 7, 2026

Astrall Dynamics presenterer den integrerte firbente brannslokkingsroboten Hypertron-T01 ved INTERSCHUTZ 2026

Indeterminate GlobeNewswire

Jun. 7, 2026

Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000

Indeterminate GlobeNewswire